Location History:
- Québec, CA (2011)
- Quebec, CA (2013)
Company Filing History:
Years Active: 2011-2013
Title: Philippe Labrie: Innovator in Nicotinic Receptor Agonists
Introduction
Philippe Labrie is a notable inventor based in Canada, recognized for his contributions to the field of pharmaceutical sciences. He holds a total of 3 patents that focus on nicotinic receptor agonists, particularly for the treatment of inflammatory diseases. His work has significant implications for therapeutic approaches in pulmonary conditions.
Latest Patents
Labrie's latest patents include innovative formulations of nicotinic receptor agonists aimed at treating inflammatory pulmonary diseases. These patents detail nicotine receptor agonists or their analogs and derivatives, along with pharmaceutical compositions that incorporate these compounds. The patents also provide specific compounds of formula wherein R1, R2, Xa, and Ya are defined, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Philippe Labrie has been associated with prestigious institutions such as Université Laval. His work at these institutions has allowed him to explore and develop groundbreaking therapeutic solutions, particularly in the realm of inflammatory diseases.
Collaborations
Labrie has collaborated with esteemed colleagues, including Yvon Cormier and Evelyne Israel-Assayag. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his innovations in the pharmaceutical field.
Conclusion
Philippe Labrie's work exemplifies the intersection of innovation and healthcare, particularly through his patents on nicotinic receptor agonists. His contributions continue to pave the way for advancements in the treatment of inflammatory diseases.